Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function. The company’s most advanced programs target NLRP3 and SARM1, with additional programs in preclinical development. You can follow Tenvie on LinkedIn.
OncoveryCare
OncoveryCare delivers comprehensive, whole-person care to cancer survivors. As the population of survivors grows rapidly alongside advances in medicine, OncoveryCare provides the personalized, longitudinal care that cancer survivors need to lead happier, healthier lives. Founded by a breast cancer survivor and led by both clinicians and survivors, OncoveryCare’s first offering is a novel Cancer Transitions of Care program, equipping each survivor with a survivorship-trained clinical team and the essential tools and skills they need to actively manage their survivorship journey.
Solv Protocol
Solv Protocol is a leading Bitcoin staking platform, powered by its innovative Staking Abstraction Layer. Solv allows Bitcoin holders to gain access to a diverse set of yield opportunities without sacrificing liquidity and enables seamless participation within DeFi ecosystems.
1Money
1Money is a stablecoin and an associated blockchain-based payment network. 1Money is building a regulated global transaction layer and yield-generating stablecoin for businesses that is efficient, cheap, and composable.
Dinari
Dinari is a real-world asset tokenization platform and distribution network focused on bringing US stocks to international and underserved markets using blockchain rails in a cheap, accessible, and secure manner.
AvenCell
AvenCell derives its name from the French word “avenir” to reflect the aim to be the FUTURE of cell therapy. AvenCell is building a truly transformative cell therapy company that targets difficult-to-treat cancers, with its lead programs focusing on acute myeloid leukemia (AML) and additional programs targeting other hematological malignancies. AvenCell was formed with the goal to create truly allogeneic cells that persist as long or longer than autologous therapies and develop a universal and switchable construct that allows complete control and target redirection of T cells after they are infused into a patient. Integration of these two platforms allows for complete separation of the manufacturing of cells from ultimate patient and cancer target, thus providing significant scalability potential at orders of magnitude more efficient than current approaches.
Bluebird Kids Health
Bluebird Kids Health reimagines pediatric primary care in underserved communities. They’re on a mission to provide exceptional care, so that every child can thrive. Their innovative pediatric value-based care model provides comprehensive, evidence-based care, tailored to the unique needs of each family. They strive for exceptional health outcomes, reduced medical costs, and an unparalleled experience for children, families, and their dedicated care teams.
Chaos Labs
Chaos Labs leads the blockchain risk management industry with innovative solutions for the evolving onchain financial landscape. The company’s Risk Platform provides comprehensive economic security for crypto protocols through advanced monitoring, real-time simulations, and cutting-edge Risk Oracles. Chaos Labs enables protocols to verify stability across all market conditions, merging offchain observability with onchain risk parameter adjustments. This empowers DeFi applications to adapt instantly to market volatility, allowing teams to monitor health, execute proactive changes, protect user funds, and optimize capital efficiency.
Kintsu
Kintsu is at the forefront of DeFi innovation, offering next-generation liquid staking infra that provides enhanced liquidity and security through composable staking rewards. Built on the Monad network, Kintsu’s platform is designed to cater to the evolving needs of the digital asset ecosystem, ensuring a seamless and potentially rewarding staking experience for users.
Paradigm
Paradigm is a unified, non-custodial liquidity network for crypto derivatives traders across CeFi and Defi. The free-to-use platform provides a single point of access to multi-asset, multi-leg, multi-protocol liquidity on-demand, without compromising on price, size, execution costs and immediacy.